Pretreatment with the ALDH2 Agonist Alda-1 Reduces Intestinal Injury Induced by Ischaemia and Reperfusion in Mice
Overview
General Medicine
Science
Authors
Affiliations
Many studies demonstrate that activation of aldehyde dehydrogenase 2 (ALDH2) protects against oxidative stress via detoxification of cytotoxic aldehydes, and could attenuate cardiac, cerebral, lung and renal ischaemia-reperfusion (I/R) injuries. However, the effect of ALDH2 in intestinal I/R is unknown. The present study was set up to determine whether an ALDH2 agonist, Alda-1, could alleviate intestinal injury after gut I/R. In a mouse model of intestinal I/R injury, histological grading, proinflammatory cytokines, oxidative stress, cellular apoptosis, chemokine contents, ALDH2 activity, 4-hydroxy--2-nonenal (4-HNE) and malondialdehyde (MDA) were evaluated. The results indicated that I/R treatment conferred elevation in pathological scores, proinflammatory cytokines, oxidative stress, cellular apoptosis and chemokine levels, accompanied by accumulated 4-HNE and MDA. No significant changes in ALDH2 activity were observed after I/R. However, Alda-1 pretreatment significantly decreased these injurious indicators, concomitant with up-regulated ALDH2 activity, and lessened 4-HNE and MDA accumulation. Taken together, our results implicate activation of ALDH2 by Alda-1 in the significant abatement intestinal I/R injury.
Yan J, Khanal S, Cao Y, Ricchiuti N, Nani A, Chen S J Mol Cell Cardiol. 2024; 197:11-19.
PMID: 39395657 PMC: 11664791. DOI: 10.1016/j.yjmcc.2024.10.003.
Targeting cell death pathways in intestinal ischemia-reperfusion injury: a comprehensive review.
Wang F, Huang H, Wei X, Tan P, Wang Z, Hu Z Cell Death Discov. 2024; 10(1):112.
PMID: 38438362 PMC: 10912430. DOI: 10.1038/s41420-024-01891-x.
Alda-1 ameliorates air embolism-induced acute lung injury.
Wu S, Chu S, Tang S, Pao H, Liao W Int J Immunopathol Pharmacol. 2023; 37:3946320231223005.
PMID: 38113877 PMC: 10734354. DOI: 10.1177/03946320231223005.
Activation of aldehyde dehydrogenase-2 improves ischemic random skin flap survival in rats.
Zhou T, Wang X, Wang K, Lin Y, Meng Z, Lan Q Front Immunol. 2023; 14:1127610.
PMID: 37441072 PMC: 10335790. DOI: 10.3389/fimmu.2023.1127610.
Yu Q, Gao J, Shao X, Lu W, Chen L, Jin L Front Med (Lausanne). 2022; 9:892472.
PMID: 35646953 PMC: 9133723. DOI: 10.3389/fmed.2022.892472.